BioMed Realty and Babraham Research Campus Announce Full Letting of Newest Life Science Development on Campus
18/10/2023
Mosaic Therapeutics, an oncology therapeutics company and alumni of Accelerate@Babraham, has agreed to take ~6,800 square feet in the newest building on Babraham Research Campus. Mosaic recently closed a $28 million Series A funding round. They will be joined in the new building by Insmed and Xap Therapeutics, both companies are scaling up from existing space on the Campus.